Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Tokyo  >  Kyowa Hakko Kirin Co Ltd    4151   JP3256000005

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on KYOWA HAKKO KIRIN CO LTD
08/17 Japan stocks higher at close of trade; Nikkei 225 up 0.49%
08/06 ArQule Reports Second Quarter 2015 Financial Results
08/06 ArQule Reports Second Quarter 2015 Financial Results
08/05 Kyowa Hakko Kirin and Bristol-Myers Squibb Announce Immuno-Oncology Clinical ..
07/31 Kyowa Hakko Kirin signs clinical trial collaboration agreement with Bristol-M..
07/30 KYOWA HAKKO KIRIN : Submits Application for Approval in Japan for Brodalumab (KH..
07/29 Kyowa Hakko Kirin, Bristol-Myers Announce Immuno-Oncology Clinical Collaborat..
07/29 KYOWA HAKKO KIRIN : New Biological and Pharmaceutical Sciences Study Findings Ha..
07/28 KYOWA HAKKO KIRIN : initiated a Pivotal Phase 3 Trial of Benralizumab (KHK4563) ..
07/27 Fujifilm Kyowa Kirin Biologics establishes joint venture with AstraZeneca to ..
07/27 KYOWA HAKKO KIRIN : Launch of Reconfigured Kyowa Hakko Kirin Global Website
07/25 Fujifilm Kyowa Kirin Biologics in joint venture with AstraZeneca
07/24 KYOWA HAKKO KIRIN : Revises Forecasts(39KB)
07/23 KYOWA HAKKO KIRIN : Researchers from Kyowa Hakko Kirin Co. Ltd. Report Details o..
07/23 KYOWA HAKKO KIRIN : Announces Results of the Phase 3 Studies of KHK4827 in Subje..
07/16 AstraZeneca Signs Benralizumab Deal With Japan's Kyowa Hakko Kirin
07/15 KYOWA HAKKO KIRIN : Studies from Kyowa Hakko Kirin Co. Ltd. Have Provided New Da..
07/10 Ultragenyx Releases Positive Interim 40-Week Bone Treatment Data From Ongoing..
07/06 KYOWA HAKKO KIRIN : Approval for ACOALAN in Japan
07/03 KYOWA HAKKO KIRIN : Approval for ACOALAN in Japan
07/03 KYOWA HAKKO KIRIN : Approval for ACOALAN® in Japan
06/26 KYOWA HAKKO KIRIN : Cantargia licenses BioWa POTELLIGENT® Technology platform fo..
06/26 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for interim dividend
06/16 KYOWA HAKKO KIRIN : Launch of REGPARA Tablets 12.5mg in Japan
06/16 KYOWA HAKKO KIRIN : Launch of REGPARA Tablets 12.5mg in Japan
06/11 KYOWA HAKKO KIRIN : Patent Application Titled "Pharmaceutical Composition Compri..
06/03 Ultragenyx Releases Positive 16-Week Interim Data From Pediatric Phase 2 Stud..
05/06 KYOWA HAKKO KIRIN : Study Data from Kyowa Hakko Kirin Co. Ltd. Provide New Insig..
05/06 ArQule Reports First Quarter 2015 Financial Results
04/09 KYOWA HAKKO KIRIN : Completion of Construction for Amino Acid Manufacturing Plan..
04/01 KYOWA HAKKO KIRIN : Entries Now Publicly Available from the 'Commitment to Life'..
04/01 KYOWA HAKKO KIRIN : Completion of Construction for New Research Building in Fuji..
03/31 KYOWA HAKKO KIRIN : Completion of Construction for New Research Building in Fuji..
03/31 KYOWA HAKKO KIRIN : Completion of Construction for New Research Building in Fuji..
03/25 KYOWA HAKKO KIRIN : Patent Issued for Pharmaceutical Composition Comprising Anti..
03/25 KYOWA HAKKO KIRIN : New Immunoglobulins Data Have Been Reported by Researchers a..
03/20 KYOWA HAKKO KIRIN : Notice regarding allotment of stock acquisition rights(stock..
03/17 KYOWA HAKKO KIRIN : KIRIN -Change in the Company Name (trade name) at DAIICHI FI..
03/09 KYOWA HAKKO KIRIN : Announces Commencement of Phase 2 Clinical Study of RTA 402 ..
03/04 KYOWA HAKKO KIRIN : Announces Commencement of Phase 2 Clinical Study of RTA 402 ..
03/04 ArQule Reports Fiscal 2014 Year End and Fourth Quarter Results
02/25 KYOWA HAKKO KIRIN : Patent Issued for Intrabuccally Rapidly Disintegrating Table..
02/18 KYOWA HAKKO KIRIN : Position and policies concerning the reduction of the minimu..
02/17 KYOWA HAKKO KIRIN : Transfer of BioWa's 'External Innovation Engine' In-Licensin..
02/17 KYOWA HAKKO KIRIN : Position and policies concerning the reduction of the minimu..
02/17 KYOWA HAKKO KIRIN : Notice regarding stock acquisition rights for the purpose of..
02/17 KYOWA HAKKO KIRIN : Transfer of BioWa's "External Innovation Engine" In-Licensin..
02/12 KYOWA HAKKO KIRIN : Patent Issued for Intrabuccally Rapidly Disintegrating Table..
01/28 KYOWA HAKKO KIRIN : Findings from Kyowa Hakko Kirin Co. Ltd. in the Area of Dysp..
01/28 KYOWA HAKKO KIRIN : Findings from Kyowa Hakko Kirin Co. Ltd. Provide New Insight..
01/10 KYOWA HAKKO KIRIN : to develop and commercialize Syndax entinostat in Japan and ..
01/08 KYOWA HAKKO KIRIN : to develop and commercialize Syndax's entinostat in Japan an..
2014 KYOWA HAKKO KIRIN CO LTD : ex-dividend day for final dividend
2014 KYOWA HAKKO KIRIN : Approval for Additional Indication for Chemotherapy-Native C..
2014 KYOWA HAKKO KIRIN : Approval for Additional Indication of NESP® for Anemia with ..
2014 Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immun..
2014 KYOWA HAKKO KIRIN : New Influenza A Virus Subtype H1N1 Study Findings Recently W..
2014 Ono Pharma, Bristol-Myers & Kyowa Hakko Kirin enter pact to condutct phase 1 ..
2014 Ono Pharmaceutical, Bristol-Myers Squibb and Kyowa Hakko Kirin Announce Immun..
2014 Kyowa Hakko Kirin -Launch of Sustained-Duration G-CSF Product G-Lasta in Japa..
2014 KYOWA HAKKO KIRIN : Launch of Sustained-Duration G-CSF Product G-Lasta® in Japan
2014 KYOWA HAKKO KIRIN : Patent Application Titled "Oligonucleotide" Published Online
2014 KYOWA HAKKO KIRIN : Completion of Construction for Drug Product Manufacturing Fa..
2014 KYOWA HAKKO KIRIN : Announces Completion of Construction for Drug Product Manufa..
2014 KYOWA HAKKO KIRIN : Completion of Construction for Drug Product Manufacturing Fa..
2014 Pfizer and Kyowa Hakko Kirin to Partner on Immuno-Oncology Combination Study
2014 Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination St..
2014 Pfizer and Kyowa Hakko Kirin to Partner on Immuno-Oncology Combination Study
2014 Approval for Sustained-Duration G-CSF Product G-Lasta in Japan
2014 KYOWA HAKKO KIRIN : Approval for Sustained-Duration G-CSF Product G-Lasta® in Ja..
2014 KYOWA HAKKO KIRIN : Announcement of Results from Long-Term Phase 1/2 Study of KR..
2014 KYOWA HAKKO KIRIN : Launch of Redesigned Kyowa Hakko Kirin Pharma Website
2014 Kyowa Hakko Kirin Announces Commencement of Phase 2b Clinical Study of KHK758..
2014 KYOWA HAKKO KIRIN : Announces Commencement of Phase 2b Clinical Study of KHK7580..
2014 KYOWA HAKKO KIRIN : Submits Application for Approval in Japan for KW-3357
1  2  3Next
Advertisement
Chart
Duration : Period :
Kyowa Hakko Kirin Co Ltd Technical Analysis Chart | 4151 | JP3256000005 | 4-Traders
Income Statement Evolution
More Financials